Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2010
09/02/2010WO2010097414A1 Improved design of small-interfering rna
09/02/2010WO2010096941A1 Methods for identifying immunobinders of cell-surface antigens
09/02/2010WO2010081152A3 Keloid derived precursor cells and its applications of use thereof
09/02/2010WO2010063138A8 A monoclonal antibody specifically binding to vegf and the hybridoma secreting same and uses thereof
09/02/2010WO2010026575A3 Adherent cells from placenta tissue and use thereof in therapy
09/02/2010WO2010008563A3 Methods and systems for manipulating particles using a fluidized bed
09/02/2010WO2009114097A4 Method of modulating t cell-dependent immune responses
09/02/2010US20100223695 NAC Transcriptional Activators Involved in Abiotic Stress Tolerance
09/02/2010US20100223691 Targeted nucleotide exchange with improved modified oligonucleotides
09/02/2010US20100223690 Compositions and methods for modulating plant disease resistance and immunity
09/02/2010US20100223689 Plants with enhanced size and growth rate
09/02/2010US20100223688 Generation of plants with improved pathogen resistance
09/02/2010US20100223685 Il-21 receptor knockout animal and methods of use thereof
09/02/2010US20100223684 Humanin receptor or humanin-like polypeptide receptor
09/02/2010US20100223683 Isolated Polynucleotide Sequence with IRES Activity
09/02/2010US20100222877 Tissue Engineered Human Pulmonary Valves with Cyclic Pressure Bioreactor Accelerated Seeding Strategies and Methods For Assessing Inflammatory Potential of Putative Scaffolds for Tissue Engineered Heart Valves
09/02/2010US20100222553 Spider silk dragline polynucleotides, polypeptides and methods of use thereof
09/02/2010US20100222424 Method of Screening Drug with the Use of 67 kDa Laminin Receptor and Drug Obtained Thereby
09/02/2010US20100222420 Compositions and methods for inhibiting ezh2
09/02/2010US20100222414 SiRNA Sequence-Independent Modification Formats for Reducing Off-Target Phenotypic Effects in RNAi, and Stabilized Forms Thereof
09/02/2010US20100222412 Modulation of glucocorticoid receptor expression
09/02/2010US20100222408 Methods and Compositions for Treatment of Cystic Fibrosis
09/02/2010US20100222407 Triblock copolymers for cytoplasmic delivery of gene-based drugs
09/02/2010US20100222380 Modified Chalcone Compounds as Antimitotic Agents
09/02/2010US20100222323 Imidazopyrazine syk inhibitors
09/02/2010US20100222318 Compounds useful as inhibitors of atr kinase
09/02/2010US20100222294 Formulations of ATP and Analogs of ATP
09/02/2010US20100222293 Modulation of sperm motility
09/02/2010US20100222267 Recombinant transferrin mutants
09/02/2010US20100222266 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides
09/02/2010US20100222264 Use of rgd-enriched gelatine-like proteins for inhibition of cancer metastasis
09/02/2010US20100222263 Atap peptides, nucleic acids encoding the same and associated methods of use
09/02/2010US20100222256 Novel polypeptide anti-HIV agent containing the same
09/02/2010US20100221836 Sol-gel materials for cellular modulation
09/02/2010US20100221835 Method for cartilage tissue regeneration via simulated microgravity culture using scaffolds
09/02/2010US20100221834 Liquid crystalline substrates for culturing cells
09/02/2010US20100221833 Process for differentiation of vascular endothelial progenitor cells from embryoid bodies derived from embryonic stem cells using hypoxic media condition
09/02/2010US20100221832 Adsorbent for lymphocyte proliferation inhibitor and treating method
09/02/2010US20100221831 Living body holding method, living body test method, living body growing method, living body holding sheet, and living body processing device
09/02/2010US20100221830 Device and Method for Ambient Storage of Fresh/Frozen Tissue Sections Via Desiccation
09/02/2010US20100221829 Media for culturing stem cells
09/02/2010US20100221828 Recombinant cell clones having increased stability and methods of making and using the same
09/02/2010US20100221827 Methods for reprogramming somatic cells
09/02/2010US20100221826 INFECTIOUS cDNA CLONE OF THE MODIFIED LIVE VIRUS VACCINE STRAIN OF EQUINE ARTERITIS VIRUS
09/02/2010US20100221825 Avian cell lines useful for the production of substances of interest
09/02/2010US20100221824 Methods and compositions for transposition using minimal segments of the eukaryotic transformation vector piggyBac
09/02/2010US20100221823 Method for culturing mammalian cells to improve recombinant protein production
09/02/2010US20100221822 Humanized and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
09/02/2010US20100221820 Use of triplex structure DNA in transferring nucleotide sequences
09/02/2010US20100221789 HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
09/02/2010US20100221782 Modified Chimeric Polypeptides With Improved Pharmacokinetic Properties
09/02/2010US20100221781 Cho-k1 cell line
09/02/2010US20100221779 Phytases, nucleic acids encoding them and methods for making and using them
09/02/2010US20100221777 Designer ligands of tgf-beta superfamily
09/02/2010US20100221773 Nucleic Acids Encoding a Functional Mammalin Purinoreceptor, P2X3, Methods of Production and Use Thereof
09/02/2010US20100221751 Method of screening endothelial cells for angiogenic capability
09/02/2010US20100221724 Patched polypeptides and uses related thereto
09/02/2010US20100221720 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
09/02/2010US20100221400 Engineering lipids in vegetative tissues of plants
09/02/2010US20100221357 Drug delivery product and methods
09/02/2010US20100221318 Nucleic acids for inhibiting hairless protein expression and methods of use thereof
09/02/2010US20100221317 Dynamin mediated diseases and associated methods and products
09/02/2010US20100221303 Method for Preparing Porous Scaffold for Tissue Engineering, Cell Culture and Cell Delivery
09/02/2010US20100221290 Mixed haptenized tumor cells and extracts and methods of treating or screening for cancer
09/02/2010US20100221288 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
09/02/2010US20100221287 Streptococcus pneumoniae Polynucleotides and Sequences
09/02/2010US20100221283 Circovirus sequences associated with piglet weight loss disease (pwd)
09/02/2010US20100221276 Circovirus sequences associated with piglet weight loss disease (pwd)
09/02/2010US20100221270 Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts
09/02/2010US20100221268 T cell immunomodulation by placenta cell preparations
09/02/2010US20100221265 Immune modulation via c-type lectin
09/02/2010US20100221262 Anti-unc5b antibodies and methods of use
09/02/2010US20100221261 Iap bir domain binding compounds
09/02/2010US20100221255 Apelin peptides and methods of use
09/02/2010US20100221249 Wisp polypeptides and nucleic acids encoding same
09/02/2010US20100221248 Directed Engagement of Activating Fc Receptors
09/02/2010US20100221246 Methods and compositions for treating cancer
09/02/2010US20100221235 Compositions and Methods for Treating Lysosomal Storage Diseases
09/02/2010US20100221231 Skin replacement compositions and methods
09/02/2010US20100221230 Elective Collection and Banking of Autologous Peripheral Blood Stem Cells
09/02/2010US20100221222 Interferons, uses and compositions related thereto
09/02/2010US20100221221 N-phenyl-2-pyrimidineamine derivatives
09/02/2010US20100221219 Compositions for treating multiple sclerosis
09/02/2010US20100221218 Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
09/02/2010US20100221209 Use of Cytokines and Mitogens to Inhibit Pathological Immune Responses
09/02/2010US20100221185 Vaccines and vaccine components for inhibition of microbial cells
09/02/2010US20100221179 IL-1 Binding Proteins
09/02/2010CA2753845A1 Novel nuclear reprogramming substance
09/02/2010CA2753829A1 .beta.-glucan-deficient gene in barley, synthetic gene, and use of same
09/02/2010CA2753679A1 Differentiation of pluripotent cells
09/02/2010CA2744103A1 Methods for identifying immunobinders of cell-surface antigens
09/01/2010EP2224010A1 Improved gene expression
09/01/2010EP2224009A1 Synthesis of sialic acid in plants
09/01/2010EP2224007A1 Gene capable of increasing the production of oil-and-fat in plant, and use thereof
09/01/2010EP2224000A1 Antibody and use thereof
09/01/2010EP2223998A1 Peptides that can bind to scurfin and uses thereof
09/01/2010EP2223939A1 Transgenic mice used as models for human pathologies originating from stem cells
09/01/2010EP2223935A2 Compounds and methods for treatment and diagnosis of chlamydial infection
09/01/2010EP2223932A1 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
09/01/2010EP2223931A1 Novel nucleic acid base pair
1 ... 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 ... 1827